Follow The Filings

RARE Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical earnings company data as of 11:02 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RARE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RARE insider trades
  • None no insider bought on the open market
  • $2.5M sold by 8 insiders outside a trading plan
  • $1.3M sold by 4 insiders under 10b5-1 plans
  1. Howard Horn CFO
    Sale
    $108K 7,066 shares at $15.27 7.3% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Theodore Alan Huizenga SVP, Chief Accounting Officer
    Planned sale
    $17K 1,283 shares at $13.57 1.9% of stake
    Traded Sep 15 Filed Sep 15
    ↗
  3. Theodore Alan Huizenga SVP, Chief Accounting Officer
    Sale
    $2,252 161 shares at $13.99 0.2% of stake
    Traded Sep 3 Filed Sep 8
    ↗
  4. Karah Herdman Parschauer EVP and Chief Legal Officer
    Planned sale
    $47K 1,900 shares at $24.92 2% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  5. Howard Horn CFO
    Planned sale
    $117K 4,696 shares at $24.92 4.6% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  6. Howard Horn CFO
    Planned sale
    $156K 4,698 shares at $33.13 4.4% of stake
    Traded Jul 1 Filed Jul 6
    ↗
  7. Corazon (Corsee) D. Sanders Director
    Sale
    $50K 2,000 shares at $25.05 8.7% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  8. Karah Herdman Parschauer EVP and Chief Legal Officer
    Planned sale
    $47K 1,899 shares at $24.62 2% of stake
    Traded Jun 15 Filed Jun 15
    ↗
  9. Howard Horn CFO
    Planned sale
    $111K 4,653 shares at $23.77 4.2% of stake
    Traded Jun 1 Filed Jun 1
    ↗
  10. Shehnaaz Suliman Director
    Planned sale
    $144K 5,740 shares at $25.12 17% of stake
    Traded May 18 Filed May 18
    ↗
  11. Eric Crombez EVP and Chief Medical Officer
    Sale
    $8,586 344 shares at $24.96 0.3% of stake
    Traded May 5 Filed May 6
    ↗
  12. Howard Horn CFO
    Planned sale
    $117K 4,683 shares at $24.90 4.1% of stake
    Traded May 1 Filed May 4
    ↗
  13. Howard Horn CFO
    Planned sale
    $98K 4,683 shares at $20.97 5.5% of stake
    Traded Apr 1 Filed Apr 2
    ↗
  14. Karah Herdman Parschauer EVP and Chief Legal Officer
    Sale
    $208K 9,526 shares at $21.87 13% of stake
    Traded Mar 6–10 Filed Mar 10
    ↗
  15. John Richard Pinion See Remarks
    Sale
    $229K 10,029 shares at $22.80 8.4% of stake
    Traded Mar 2 Filed Mar 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 22 stock grants and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 8.01 Filing Doc
8-K 1.01 Filing Doc
8-K 1.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.